Navigation Links
The Honorable Edward M. Kennedy, Scientists Mina J. Bissell and Susan Band Horwitz, and Philanthropist Jon M. Huntsman to Receive American Cancer Society Highest Honor for Outstanding Contributions to Cancer Fight
Date:11/21/2008

Society's Medal of Honor to be Awarded on November 21

NEW YORK, Nov. 21 /PRNewswire-USNewswire/ -- The American Cancer Society -- the nation's leading voluntary health organization and largest non-governmental funder of cancer research and discovery -- will present its highest honor, the Medal of Honor, to four Americans who have made outstanding contributions to the fight against cancer. This year's winners, who will receive their awards at a ceremony during the American Cancer Society's annual meeting in New York City, are: The Honorable Edward M. Kennedy, United States Senator from Massachusetts, for Cancer Control; Mina J. Bissell, Ph.D., for Basic Research; Susan Band Horwitz, Ph.D., for Clinical Research; and Jon M. Huntsman for Cancer Philanthropy. The Medal of Honor, originally called the American Cancer Society Award, was first given in 1949.

Sen. Edward "Ted" Kennedy will be awarded the Medal of Honor for Cancer Control. Sen. Kennedy (D-Mass.) is one of the great champions in the legislative fight against cancer. Throughout his more than 40 years in the U.S. Senate, he has fought tirelessly for health care-related causes, from equal access to health care to increased funding for cancer research and early detection cancer screenings. By authoring legislation on a variety of issues, Time magazine, in a 2006 article, speculated his work has affected the lives of virtually every "man, woman and child in the country."

Sen. Kennedy has been a passionate supporter of cancer research funding from his early days in office. As chairman of the Senate's health subcommittee in 1971, he led the passage of the National Cancer Act, which is widely considered the most dramatic piece of health legislation ever enacted. Representing a concerted national campaign against cancer, the law authorized increased funding for federal cancer research; today, it enables funding of more than $4 billion per yea
'/>"/>

SOURCE American Cancer Society
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Media Advisory - Minister of Health, the Honorable Tony Clement to announce partnership between Canadas Cancer Stem Cell Consortium and the California Institute for Regenerative Medicine for international collaboration to advance cancer stem cell researc
2. Healthcare Businesswomens Association Names Genentechs Leonard Kanavy, Vice President, Commercial Operations as the 2008 Honorable Mentor
3. ORBIS International Announces the Death of the Honorable Oliver Foot, President and Board Member
4. Elizabeth Edwards Reschedules Metro Detroit Appearance
5. Aflac Cancer Center and Blood Disorders Service Unveils New Carl Edwards Triage Room
6. Elizabeth Edwards to be Opening Speaker at National Hospice Conference in Dallas
7. Edwards Lifesciences Board Approves New $250 Million Share Repurchase Program
8. Edwards Lifesciences to Present at the Goldman Sachs 29th Annual Global Healthcare Conference
9. Edwards Lifesciences Receives Additional Questions From the FDA About the LifeStent Product Line
10. Aflac to be Primary Sponsor of Carl Edwards and the No. 99 Ford Fusion
11. MediVoice Announces Appointment of Edward J. Zecchini as Chief Operating Officer & Chief Technology Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...RNewswire/--NIP,Inc.todayannouncedtheacquisitionof...ingexecutivecompensationandbenefitplanprovidershea...esinLosAngeles,Milwaukee,Boston,ChicagoandAtlanta....ertintheexecutivebenefitsindustry. ,, "Weareexc...gnificantmarketpresence,"statesBillPollock,Chairma...
(Date:11/24/2009)...Nov.24/PRNewswire/--Nextmonth,UnitedHealthcarewill...gHispanic-AmericanseniorsunderstandthebasicsofMedi...eafreeZumba®Goldclass,aLatin-infusedfitnesspr...umba,andtango. ,, UnitedHealthcarewillofferthes...engagedwhenlearningabouttheirhealthcareoptions. T...
(Date:11/24/2009)...ewswire/--TheUnionLaborLifeInsuranceCompany("Union...#174;),()thenation,slargestvisionbenefitsandservic...tounions,uniontrustfunds,unionemployersandtheirmem...servicesincludingcomprehensiveeyeexams,broadselect...ntqualityeyecareis,"statedBruceSmith,NationalSales...
(Date:11/24/2009)... help ward off peripheral artery disease, researc... News) -- Among people aged 75 and older, the herb... attacks, stroke or death, a new study finds. ,...medy might help prevent the leg-circulation proble..., Ginkgo contains nutrients called flavonoids, whi...
(Date:11/24/2009)...t differ greatly between high- and low-volume cent...ealthDay News) -- Do hospitals that conduct the mo...lts for patients? Maybe not. , Prior research h... comes to artery-opening procedures, but a new stu...igh-volume hospitals performing more or less equal...
Breaking Medicine News(10 mins):Health News:NIP Acquires San Diego Executive Benefits Firm 2Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2Health News:Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 3Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3
...tuberculosis drug, currently in the experimental p... drug resistant and latent infections as well. The...// than those used for conventional treatment. ...d spectrum of non-pathogenic microorganisms that e...
...s to be profound links between land-based pollutio...o scientists, physicians, and veterinarians, that .../ According to Paul Sandifer, Chief Scientist ...ues of our unseen impact on the sea, there is moun...
...s come into existence to protect the traditional k...es. Charles McManis, J.D., IP and technology law ...at Washington University in St. Louis has come wit...hey said that existing intellectual property regim...
...Cunnane, a metabolic physiologist at the Universit...d secure shore-based diet that fuelled and provide...they are today. Early hominid brains // underwent ...owth. Our brains weigh roughly twice as much as th...
...titioned for reduction on VAT for condoms, to be r...arrant abolishment of VAT on condoms, the best tha...gly invoked a re-categorization of condoms from a ...m Fins bury, a High Street retailer, who wishes an...
...ty of Jerusalem researchers report that another he...duce cholesterol in blood. As a result it reduces ... has found that heart patients who eat one grapefr... in the reduction of incidence of heart ailments a...
Other Medicine News:Health News:New Drug Promises Hope In Multiple Drug Resistant And Latent TB Treatment 2Health News:Mystery behind the evolution of the Human brain 2Health News:One fruit that has captured the health benefit sector is Grapefruit! 2
(Date:11/24/2009)...OXThanksgivingDaytelevisionspecialcalled"Kaleidosc...ttheholidaysareatimetobegratefulformanydevelopment...tbattleeachdayassurvivors,caregivers,andadvocates....eiceofcancersurvivorsScottHamiltonandDorothyHamill...rwhowillperform"HopeisAlwaysHere,"asongwrittenbych...
(Date:11/24/2009)...e-FirstCall/--BioSpecificsTechnologiesCorp.(Nasdaq...nclasscollagenase-basedproducts,todayannouncedthat...pcomingPiperJaffray21stAnnualHealthCareConferenceo...ceHotelinNewYork,NY. ,, Alivewebcastofthepresen...estorRelationssectionoftheCompany,swebsiteat www.b...
(Date:11/23/2009)...ooftheChicagoarea,sleadingBoardCertifiedDiagnostic...aging,couplingthelatesttechnologyindigitalmammogra...tytohavethefullrangeofdigitalimagingcompleted,diag...ffice.Drs.AhmedFaragandJoanWerberaredeliveringthis...waitforanappointmentcommonlyfoundinChicago,fromthe...
Breaking Medicine Technology:FOX Thanksgiving Day Special 'Kaleidoscope' Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 2FOX Thanksgiving Day Special 'Kaleidoscope' Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 3Nu Skin Chairman Recognized With 2009 International Award for Outstanding Business Performance 51656 1Nu Skin Chairman Recognized With 2009 International Award for Outstanding Business Performance 51656 2Nu Skin Chairman Recognized With 2009 International Award for Outstanding Business Performance 51656 3New HHS HRSA Grant Will Fund Development of an Electronic Genetic and Family History Record for Doctors Offices 51651 1New HHS HRSA Grant Will Fund Development of an Electronic Genetic and Family History Record for Doctors Offices 51651 2New HHS HRSA Grant Will Fund Development of an Electronic Genetic and Family History Record for Doctors Offices 51651 3Resurrection Medical Center Among Top 5 25 of Hospitals Nationwide for Womens Health 51646 1Resurrection Medical Center Among Top 5 25 of Hospitals Nationwide for Womens Health 51646 2
...ual Meeting of EASL , , Management to Discuss Stu...Results Call at 5 P.M. EDT Today , , SAN DIEGO, ...ANDS ) today announced that ANA598, the Company,s ...r, demonstrated potent antiviral activity at all d...udy in which patients chronically infected with th...
...d nearly double SVR rate compared to standard of c...hibitor SCH 900518 presented at EASL annual meetin...ugh Corporation (NYSE: SGP ) today reported that...ceprevir, its investigational oral hepatitis C pro... alfa-2b and ribavirin, significantly increased su...
Other Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 2ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 3ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 4ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 5ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 6ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 7ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 8Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 2Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 3Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 4Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 5Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 6Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 7Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 8Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 9Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 10Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 11Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 12
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
Medicine Products: